Friday, July 12, 2013

GranuFlo Complications Lead to 11 Patient Deaths

A total of 11 dialysis patients have died after undergoing dialysis treatment using Granuflo and Naturalyte, according to the latest news on Fresenius’ problematic dialysis products. Unsurprisingly, the loved ones of these alleged victims have filed a Granuflo lawsuit against Fresenius Medical Care, demanding compensation for all the damages they have suffered. These lawsuits were filed in various courts across the country, including Georgia, Ohio, Kentucky, Virginia, Texas, Illinois, California, and Florida. Based on released court documents, the deaths occurred between 2010 and 2012.

Granuflo and Naturalyte are dry acid concentrates used in dialysis treatment. Both of these dialysates are produced by Fresenius Medical Care, the largest operator of dialysis facilities in the United States. They were first introduced to the market in the year 2003, after which they became very popular. Despite their popularity, however, many dialysis patients reportedly developed severe complications. As a course of action, the manufacturing company conducted research studies to determine the safety of its dialysis products.

Findings from these studies reportedly linked the use of Naturalyte and Granuflo to an increased risk of heart attacks and strokes. Apparently, many of the patients involved in the study developed heart-related complications after being administered with the dialysis products. In fact, some patients have reportedly died due to the severity of their conditions.   

When Fresenius found out about the dangers of Granuflo and Naturalyte, the company immediately sent a warning memo to its own dialysis centers. However, it had failed to warn other facilities that use the products in a timely manner. Even so, a copy of the said memo was anonymously sent to the U.S. Food and Drug Administration (FDA) a year later, which prompted the agency to issue a class I recall of Naturalyte and Granuflo.

After the recall of Granuflo and Naturalyte, many injured patients pressed charges against the manufacturing company, Fresenius Medical Care. Based on these filed lawsuits, the dialysis products may potentially cause fatal injuries, such as heart attacks, strokes, and other heart-related adverse effects. More information pertaining to safety concerns and lawsuits involving Granuflo and Naturalyte may be found in articles published on personal injury law firm websites, including the Rottenstein Law Group’s rotlaw.com.




No comments:

Post a Comment